Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs PJP overlap: 38% of top holdings shared

Bottom line

How much do XLV and PJP overlap?

38% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 54.8% of XLV's assets and 46.9% of PJP's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

XLVPJP
Weight overlap (top 25)38%
Shared holdings10
Weight in shared holdings54.8%46.9%
Total positions6533
Expense ratio0.08%0.58%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings XLV and PJP have in common

Holding% of XLV% of PJPOverlap
Eli Lilly & Co16.51%5.02%5.02%
Johnson & Johnson10.64%5.18%5.18%
AbbVie Inc7.74%5.48%5.48%
Merck & Co Inc5.52%5.06%5.06%
Amgen Inc3.40%5.33%3.40%
Abbott Laboratories2.75%5.67%2.75%
Gilead Sciences Inc2.73%4.53%2.73%
Pfizer Inc2.39%4.50%2.39%
Bristol-Myers Squibb Co2.05%2.94%2.05%
Regeneron Pharmaceuticals Inc1.08%3.14%1.08%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. UnitedHealth Group Inc — 6.57%
  2. Thermo Fisher Scientific Inc — 3.24%
  3. Intuitive Surgical Inc — 2.45%
  4. CVS Health Corp — 2.30%
  5. Vertex Pharmaceuticals Inc — 2.19%
  6. Danaher Corp — 2.09%
  7. Stryker Corp — 1.89%
  8. Medtronic PLC — 1.75%
  9. McKesson Corp — 1.58%
  10. Elevance Health Inc — 1.46%
  11. Cigna Group/The — 1.27%
  12. Boston Scientific Corp — 1.10%
  13. HCA Healthcare Inc — 1.05%
  14. Cardinal Health Inc — 0.97%
  15. Cencora Inc — 0.96%

Only in PJP

  1. Invesco Private Prime Fund — 7.93%
  2. Corcept Therapeutics Inc. — 4.96%
  3. Amneal Pharmaceuticals, Inc. — 3.75%
  4. Invesco Private Government Fund — 3.73%
  5. Liquidia Corp. — 3.66%
  6. Travere Therapeutics, Inc. — 3.30%
  7. Ligand Pharmaceuticals Inc. — 3.20%
  8. Harmony Biosciences Holdings, Inc. — 3.06%
  9. Viatris Inc. — 2.83%
  10. Jazz Pharmaceuticals PLC — 2.79%
  11. Biogen Inc. — 2.75%
  12. Collegium Pharmaceutical, Inc. — 2.74%
  13. Prestige Consumer Healthcare Inc. — 2.74%
  14. Ocular Therapeutix, Inc. — 2.58%
  15. ANI Pharmaceuticals, Inc. — 2.55%

Asset mix

Asset typeXLVPJP
Stocks99.7%99.9%
Cash & short-term funds0.3%11.8%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryXLVPJP
US97.9%106.5%
IE2.1%5.2%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do XLV and PJP overlap?
About 38% by weight. 10 securities appear in both funds' top 25 holdings; they make up 54.8% of XLV's assets and 46.9% of PJP's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do XLV and PJP have in common?
The largest shared holdings are AbbVie Inc, Johnson & Johnson, Merck & Co Inc, Eli Lilly & Co, Amgen Inc.
Should I own both XLV and PJP?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, XLV or PJP?
XLV is broader, with 65 positions versus 33 for PJP. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.